Background We examined differences in receipt of guideline-compliant care in patients with
early-onset versus average-onset biliary tract cancers (BTC) in localized or metastatic …

Abstract Background The National Comprehensive Cancer Network (NCCN) guidelines
recommend chemotherapy for patients with inoperable biliary tract cancers (BTC), as well as …

Background Biliary tract cancers are rare aggressive malignancies typically diagnosed
when the disease is metastatic or unresectable, precluding curative treatment. Objective We …

Background Recommended treatments of patients with advanced biliary tract cancer (aBTC)
are limited to one chemotherapy doublet. Nevertheless, efficacy of treatment personalisation …

Abstract Background & Aims Accumulating data has shown the rising incidence and poor
prognosis of early‐onset gastrointestinal cancers, but few data exist on biliary tract cancers …

Background Limited data are available regarding second‐line (2 L) treatment for advanced
or metastatic biliary tract cancers (BTC) in the US real‐world setting. This study explores the …

398 Background: The American Cancer Society estimates 11,980 new cases of biliary tract
cancers (BTCs), including gall bladder and nearby large bile ducts, to occur in the US in …

Background There are limited data available on treatment patterns and outcomes of biliary
tract cancers (BTCs) in Canada. The aim of this study was to understand treatment patterns …

Background Biliary tract cancers (BTCs), a heterogeneous group of cancers arising from the
biliary tract, account for∼ 15% of primary liver cancers. Patients are often diagnosed with …

Patterns of care and treatment outcomes in older patients with biliary tract cancer - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …